Interaction of caspase-3 with the cyclic GMP binding cyclic GMP specific phosphodiesterase (PDE5a1)

European Journal of Biochemistry

Volumn 270, Issue 5, 2003, Pages 962-970

  Frame, Mhairi J ^a   Tate, Rothwelle ^a   Adams, David R ^b   Morgan, Keith M ^b   Houslay, M D ^c   Vandenabeele, Peter ^d   Pyne, Nigel J ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b HERIOT WATT UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Apoptosis; Caspases; Cyclic GMP; Phosphodiesterase; Proteases

Indexed keywords

AMINO ACID; APOPTOSIS INDUCING FACTOR; CASPASE 3; CYCLIC GMP; PHOSPHODIESTERASE; RECOMBINANT PROTEIN; STAUROSPORINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CATTLE; CELL STRAIN; CELL STRAIN COS7; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME DEGRADATION; ENZYME SUBSTRATE COMPLEX; GEL FILTRATION CHROMATOGRAPHY; GENETIC TRANSFECTION; HYDROLYSIS; MOLECULAR MODEL; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; WILD TYPE;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CATTLE; COS CELLS; DNA, COMPLEMENTARY; ENZYME INHIBITORS; HYDROLYSIS; MODELS, MOLECULAR; PC12 CELLS; PROTEIN BINDING; RATS; STAUROSPORINE;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0037337139     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2003.03464.x     Document Type: Article

References (36)

1. Beavo, J.A. (1995) Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75, 725-748.
2. Beavo, J.A. & Brunton, L.L. (2002) Cyclic nucleotide research -still expanding after half a century. Nat. Rev. Mol. Cell. Biol. 3 (9), 710-718.
3. Houslay, M.D. & Adams, D.R. (2003) PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitisation and compartmentalisation. Biochem. J. 370, 1-18.
4. Corbin, J.D. & Francis, S.H. (1999) Cyclic GMP phosphodiesterase-5: target of sildenafil. J. Biol. Chem. 274, 13729-13732.
5. McAllister-Lucas, L.M., Sonnenburg, W.K., Kadlecek, A., Seger, D., Trong, H.L., Colbran, J.L., Thomas, M.K., Walsh, K.A., Francis, S.H., Corbin, J.D. & Beavo, J. (1993) The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone. J. Biol. Chem. 268, 22863-22873.
6. Thomas, M.K., Francis, S.H. & Corbin, J. (1990) Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J. Biol. Chem. 265, 14964-14970.
7. Burns, F., Rodger, I.W. & Pyne, N.J. (1992) The catalytic subunit of protein kinase A triggers activation of the type V cyclic GMP-specific phosphodiesterase from guinea-pig lung. Biochem. J. 283, 487-491.
8. Frame, M., Wan, K.-F., Tate, R., Vandenabeele, P. & Pyne, N.J. (2001) The gamma subunit of the rod photoreceptor cGMP phosphodiesterase can modulate the proteolysis of two cGMP binding cGMP-specific phosphodiesterases (PDE6 and PDE5) by caspase-3. Cell. Signal. 13, 735-741.
9. Aravind, L. & Ponting, C.P. (1997) The GAF domain: an evolutionary link between diverse phototransducing proteins. Trends Biochem. Sci. 22, 458-459.
10. Ho, Y.S., Burden, L.M. & Hurley, J.H. (2000) Structure of the GAF domain, a ubiquitous signaling motif and a new class of cyclic GMP receptor. EMBO J. 19, 5288-5299.
11. Martinez, S.E., Wu, A.Y., Glavas, N.A., Tang, X.B., Turley, S., Hol, W.G. & Beavo, J.A. (2002) The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding. Proc. Natl. Acad. Sci. USA 99, 13260-13265.
12. McAllister-Lucas, L.M., Haik, T.L., Colbran, J.L., Sonnenburg, W.K., Seger, D., Turko, I.V., Beavo, J.A., Francis, S.H. & Corbin, J.D. (1998) An essential aspartic acid at each of two allosteric cGMP-binding sites of a cGMP-specific phosphodiesterase. J. Biol. Chem. 270, 30671-30679.
13. Turko, I.V., Francis, S.H. & Corbin, J.D. (1998) Hydropathic analysis and mutagenesis of the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). cGMP versus cAMP substrate selectivity. Biochemistry 37, 4200-4205.
14. Turko, I.V., Francis, S.H. & Corbin, J.D. (1998) Potential roles of conserved amino acids in the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase. J. Biol. Chem. 273, 6460-4466.
15. Francis, S.H., Turko, I.V., Grimes, K.A. & Corbin, J.D. (2000) Histidine-607 and histidine-643 provide important interactions for metal support of catalysis in phosphodiesterase-5. Biochemistry 39, 9591-9596.
16. Nunez, G., Benedict, M.A., Hu, Y.M. & Inohara, N. (1998) Caspases: the proteases of the apoptotic pathway. Oncogene 17, 3237-3245.
17. Alnemri, E.S., Fernandes-Alnemri, T. & Litwack, G. (1995) Cloning and expression of four novel isoforms of human interleukin-1 beta converting enzyme with different apoptotic activities. J. Biol. Chem. 270, 4312-4317.
18. Hengartner, M.O., Ells, R.E. & Horvitz, H.R. (1992) Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356, 494-499.
19. Van De Craen, M., Vandenabeele, P., Declercq, W., Van Den Brande, I., Van Loo, G., Molemans, F., Schotte, P., Van Criekinge, W., Beyaert, R. & Friers, W. (1997) Characterization of seven murine caspase family members. FEBS Lett. 403, 61-69.
20. Van De Craen, M., Declercq, W., Van Den Brande, I., Friers, W. & Vandenabeele, P. (1999) The proteolytic procaspase activation network: an in vitro analysis. Cell Death Differ. 11, 1117-1124.
21. Cardone, M.H., Salvesen, G.S., Widmann, C., Johnson, G. & Frisch, S.M. (1997) The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 90, 315-323.
22. Graves, J.D., Gotoh, Y., Draves, K.E., Ambrose, D., Han, D.K., Wright, M., Chernoff, J., Clark, E.A. & Krebs, E.G. (1998) Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J. 17, 2224-2234.
23. Rudel, T. & Bokoch, G.M. (1997) Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276, 1571-1574.
24. Francois, F. & Grimes, M.L. (1999) Phosphorylation-dependent Akt cleavage in neural cell in vitro reconstitution of apoptosis. J. Neurochem. 73, 1773-1776.
25. Frutos, S., Moscat, J. & Diaz-Meco, M.T. (1999) Cleavage of zetaPKC but not lambda/iotaPKC by caspase-3 during UV-induced apoptosis. J. Biol. Chem. 274, 10765-10770.
26. Van de Water, B., Nagelkerke, J.F. & Stevens, J.L. (1999) Dephosphorylation of focal adhesion kinase (FAK) and loss of focal contacts precede caspase-mediated cleavage of FAK during apoptosis in renal epithelial cells. J. Biol. Chem. 274, 13328-13337.
27. Baixeras, E., Garcia-Lozano, E. & Martinez, A.-C. (1996) Decrease in cAMP levels promoted by CD48-CD2 interaction correlates with inhibition of apoptosis in B cells. Scan. J. Immunol. 43, 406-412.
28. Tortorella, C., Piazzolla, G., Spaccavento, F. & Antonaci, S. (1998) Effects of granulocyte-macrophage colony-stimulating factor and cyclic AMP interaction on human neutrophil apoptosis. Med. Inflamm. 7, 391-396.
29. Shimojo, T., Hiroe, M., Ishiyama, S., Ito, H., Nishikawa, T. & Marumo, F. (1999) Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. Exp. Cell. Res. 247, 38-47.
30. Li, Y., Maher, P. & Schubert, D. (1997) Requirement for cGMP in nerve cell death caused by glutathione depletion. J. Cell. Biol. 139, 1317-1324.
31. Huston, E., Beard, M., McCallum, F., Pyne, N.J., Vandenabeele, P., Scotland, G. & Houslay, M.D. (2000) The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3. Consequences for altered intracellular distribution. J. Biol. Chem. 275, 28063-28074.
32. Stennicke, H.R., Jurgansmeier, J.M., Shin, H., Deveraux, Q., Wolf, B.B., Yang, X., Zhou, Q., Ellerby, H.M., Bredesen, D., Green, D.R., Froelich, C.J. & Salvesen, G.S. (1998) Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 273, 27084-27090.
33. Thompson, J. & Appleman, M. (1971) Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10, 311-316.
34. Xu, R.Y., Hassell, A.M., Vanderwall, D., Lambert, M.H., Holmes, W.D., Luther, M.A., Rocque, W.J., Milburn, M.U., Zhao, Y., Ke, H. & Nolte, R.T. (2000) Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity. Science 288, 1822-1825.
35. Brophy, V.A., Tavare, J.M. & Rivett, A.J. (2002) Treatment of COS-7 cells with proteasome inhibitors or gamma-interferon reduces the increase in caspase 3 activity associated with staurosporine-induced apoptosis. Arch. Biochem. Biophys. 397, 199-205.
36. Richter, W., Unciuleac, L., Hermsdorf, T., Kronbach, T. & Dettmer, D. (2001) Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4. Cell. Signall. 13, 287-297.